Melanotan 2
$50.00 (USD)
Melanotan 2 (MT-2) is a synthetic cyclic heptapeptide analogue of the endogenous alpha-melanocyte-stimulating hormone (α-MSH).
In research settings, it is widely utilized to investigate the melanocortin system’s role in regulating skin pigmentation (melanogenesis), sexual behavior, and energy homeostasis (appetite suppression) through non-selective activation of melanocortin receptors.
Note: This product is intended for research use only and is not for human consumption.
Melanotan 2 was originally developed to study the stimulation of melanin production without the need for ultraviolet (UV) radiation exposure. Research indicates that unlike its predecessor Melanotan I (Afamelanotide), MT-2 acts as a non-selective agonist with high affinity for MC1, MC3, MC4, and MC5 receptors.
This broad receptor binding profile allows researchers to explore multiple physiological pathways simultaneously: the activation of MC1R leads to increased melanogenesis (tanning), while binding to MC3R and MC4R in the central nervous system is linked to effects on sexual arousal and metabolic regulation (reduced food intake). Its cyclic lactam structure protects it from rapid enzymatic degradation, offering significantly higher potency and stability in experimental models compared to linear α-MSH.
Product Specifications:
-
Sequence: Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
-
Molecular Formula: C50H69N15O9
-
Molecular Weight: 1024.2 g/mol
-
CAS Number: 121062-08-6
-
Purity: ≥99% (HPLC)
-
Form: Lyophilized White Powder
Storage & Handling:
Lyophilized Melanotan 2 is stable at room temperature for short durations (up to 3 weeks) but should be stored desiccated below -18°C for long-term stability (1-2+ years). Upon reconstitution with bacteriostatic water, the solution must be stored at 4°C (refrigerated) and used within 30-60 days to prevent degradation and loss of potency.
Disclaimer:
All products listed on this website, including Melanotan 2, are for laboratory research purposes only. They are not intended for use as drugs, food additives, or cosmetic products. This product is not approved by the FDA for human use and should not be ingested or administered to humans or animals.
FAQ
What is the difference between Melanotan 2 and PT-141?
Melanotan 2 is the parent peptide from which PT-141 (Bremelanotide) was derived. While MT-2 activates the MC1 receptor (causing tanning) in addition to CNS receptors, PT-141 is a metabolite of MT-2 that lacks the C-terminal amide group responsible for strong MC1R binding. This makes PT-141 more specific for sexual function research without the tanning side effect.
Why is it called a “non-selective” agonist?
“Non-selective” means that Melanotan 2 binds to multiple types of melanocortin receptors (MC1, MC3, MC4, MC5) rather than just one. This is why research on MT-2 observes a wide range of effects, including pigmentation, appetite suppression, and libido enhancement, rather than a single isolated outcome.
Does Melanotan 2 require UV exposure in research?
While MT-2 stimulates melanin production independently, research suggests that the presence of UV light can potentiate the melanogenic process. However, the peptide itself is capable of upregulating the enzymatic machinery (tyrosinase) for pigmentation without direct UV radiation.
How long does the reconstituted peptide last?
Once mixed with bacteriostatic water, Melanotan 2 is reasonably stable if kept refrigerated (2-8°C). Standard laboratory protocols recommend using the reconstituted solution within 4-8 weeks to ensure data consistency, as peptides in solution slowly degrade over time.
Related Products
GLP-3RT is an investigational multi-receptor agonist peptide designed to target multiple metabolic hormone pathways involved in appetite, energy expenditure, and glucose regulation.
It is most often described as a next-generation approach to weight-management research due to its combined incretin and glucagon-pathway activity.
This injectable peptide is primarily referenced in the context of clinical development and advanced metabolic research.
Cagrisema is a potent new blend, a combination that integrates two peptides – cagrilintide and semaglutide.
Semaglutide is a GLP-1 receptor agonist; a version of human GLP-1 hormone, modified to resist the degradation by the enzyme dipeptidyl peptidase-4.
Cagrilintdide, on the other hand, is an amylin analogue. Its role is to mimic the human hormone amylin and is structurally designed to be resistant to enzymatic degradation.
Together, these two peptides profoundly influence chemical structures and induce hormonal changes:
- Leading to the receptor changes within the pancreas and the brain
- Boosting insulin secretion
- Interacting with the receptors involved in appetite regulation
- Mimicking the action of amylin
- Decreasing glucagon secretion
All in all, this is a sophisticated, more importantly, incredibly potent combination of two peptides whose actions complement each other. Cagrisema combination influences some key hormonal processes and plays a role in metabolic regulation.
GLP-2TZ is a synthetic peptide investigated and used clinically for its incretin-based metabolic activity, designed to activate key pathways involved in glycemic control and appetite regulation.
As a dual incretin receptor agonist (GIP/GLP‑1), it is associated with clinically meaningful effects on body weight and metabolic markers in studied populations.
This injectable peptide is typically positioned for advanced metabolic research where receptor-driven appetite and glucose signaling are the primary focus.
GLP-1SG is a derivative of the naturally occurring GLP-1, a peptide that has been shown to lower blood sugar levels and enhance insulin secretion. Research shows that GLP-1SG may also improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimer’s disease. Research with GLP-1SG has shown it can significantly decrease appetite by delaying gastric emptying and reducing intestinal motility. Glucagon-Like Peptide-1 (GLP-1) Analogs have been shown to stimulate insulin and suppress glucagon secretion in a glucose-dependent manner.
Size: 5mg / 10mg
Contents: GLP-1SG
Form: Lyophilized powder
Purity: >99%
AOD9604 is a derivative of human growth hormone (hGH) and a modified version of the hGH fragment 176-191 peptide, incorporating a di-sulfide bridge. What’s exciting about this peptide is that it does not affect IGF-1 or insulin levels and is, therefore, not a risk in promoting glucose intolerance.
Buy Cagrilintide Online
Cagrilintide is a long-acting amylin analogue, currently at the forefront of peptide research due to its rather interesting potential beneficial effect in individuals with diabetes. But what’s so special about amylin? Well, amylin is another peptide hormone, co-secreted with insulin, which inhibits food intake, delays gastric emptying, and, most importantly, reduces blood glucose levels.
Back to cagrilintide… it was originally developed to improve on the initial amylin analogue called pramlintide. The problem with pramlintide is its short half-life and undesired side effects.
Cagrilintide was (and still is being) developed to alter the half-life, potency and stability of pramlintide, and other amylin analogues.Since, it’s still a relatively new peptide, it still needs to undergo further research so we can make sure its as effective and safe.
